Zobrazeno 1 - 10
of 3 553
pro vyhledávání: '"Menvielle, G"'
Autor:
Pagliuca M; Cancer Survivorship Research Group, INSERM U981, Gustave Roussy, Villejuif, France.; Departement of Breast and Thoracic Oncology, Division of Breast Medical Oncology, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Napoli, Italia., Havas J; Cancer Survivorship Research Group, INSERM U981, Gustave Roussy, Villejuif, France., Thomas E; Labex DEV2CAN, Institut Convergence Plascan, Centre Léon Bérard, Gilles Thomas Bioinformatics Platform, UMR INSERM 1052, CNRS 5286, Université Claude Bernard, Lyon 1, Lyon, France., Drouet Y; Labex DEV2CAN, Institut Convergence Plascan, Centre Léon Bérard, Gilles Thomas Bioinformatics Platform, UMR INSERM 1052, CNRS 5286, Université Claude Bernard, Lyon 1, Lyon, France., Soldato D; Cancer Survivorship Research Group, INSERM U981, Gustave Roussy, Villejuif, France., Franzoi MA; Cancer Survivorship Research Group, INSERM U981, Gustave Roussy, Villejuif, France., Ribeiro J; Cancer Survivorship Research Group, INSERM U981, Gustave Roussy, Villejuif, France., Chiodi CK; Cancer Survivorship Research Group, INSERM U981, Gustave Roussy, Villejuif, France., Gillanders E; Cancer Survivorship Research Group, INSERM U981, Gustave Roussy, Villejuif, France., Pistilli B; Medical Oncology Department, INSERM U981, Gustave Roussy, Villejuif, France., Menvielle G; Cancer Survivorship Research Group, INSERM U981, Gustave Roussy, Villejuif, France., Joly F; Clinical Research Depatment, Inserm U1086 Anticipe, Centre Francois Baclesse, University UniCaen, Caen, France., Lerebours F; Medical Oncology Department, Institut Curie Saint Cloud, Saint Cloud, France., Rigal O; Medical Oncology Department, Centre Henri Becquerel, Rouen, France., Petit T; Medical Oncology Department, Institute of Cancer Strasbourg (ICANS), Strasbourg, France., Giacchetti S; Department of Breast Disease, APHP, University Hospital Saint Louis, Senopole, Paris, France., Dalenc F; Medical Oncology Department, Oncopole Claudius Regaud, Institut Universitaire du Cancer, Toulouse, France., Wassermann J; Medical Oncology Department, Pitié Salpêtrière University Hospital, Cancer University Institute, AP-HP, Paris, France., Arsene O; Medical Oncology Department, Centre Hospitalier de Blois, Blois, France., Martin AL; Direction des Data et des Partenariats, UNICANCER, Paris, France., Everhard S; Direction des Data et des Partenariats, UNICANCER, Paris, France., Tredan O; Labex DEV2CAN, Institut Convergence Plascan, Centre Léon Bérard, Gilles Thomas Bioinformatics Platform, UMR INSERM 1052, CNRS 5286, Université Claude Bernard, Lyon 1, Lyon, France., Boyault S; Labex DEV2CAN, Institut Convergence Plascan, Centre Léon Bérard, Gilles Thomas Bioinformatics Platform, UMR INSERM 1052, CNRS 5286, Université Claude Bernard, Lyon 1, Lyon, France., De Laurentiis M; Departement of Breast and Thoracic Oncology, Division of Breast Medical Oncology, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Napoli, Italia., Viari A; Labex DEV2CAN, Institut Convergence Plascan, Centre Léon Bérard, Gilles Thomas Bioinformatics Platform, UMR INSERM 1052, CNRS 5286, Université Claude Bernard, Lyon 1, Lyon, France., Deleuze JF; Centre National de Recherche en Génomique Humaine CNRGH-CEA, Laboratory of Excellence in Medical Genomics, GENMED, Évry-Courcouronnes, France., Bertaut A; Unit of Methodology and Biostatistics, George-François Leclerc Cancer Center, Dijon, France., André F; Cancer Survivorship Research Group, INSERM U981, Gustave Roussy, Villejuif, France., Vaz-Luis I; Cancer Survivorship Research Group, INSERM U981, Gustave Roussy, Villejuif, France.; Department for the Organization of Patient Pathways (DIOPP), Gustave Roussy, Villejuif, France., Di Meglio A; Cancer Survivorship Research Group, INSERM U981, Gustave Roussy, Villejuif, France.
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2024 Sep 09. Date of Electronic Publication: 2024 Sep 09.
Autor:
Sandoval JL; Unit of Population Epidemiology, Division of Primary Care, Department of Health and Community Medicine, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Division of Oncology, Department of Oncology, Geneva University Hospitals, Geneva, Switzerland., Franzoi MA; Unit of Molecular Predictors and New Targets in Oncology, INSERM, Gustave Roussy Institute, University Paris Saclay, Villejuif, France., di Meglio A; Unit of Molecular Predictors and New Targets in Oncology, INSERM, Gustave Roussy Institute, University Paris Saclay, Villejuif, France.; Medical Oncology Department, Gustave Roussy Institute, Villejuif, France., Ferreira AR; Universidade Católica Portuguesa, Lisbon, Portugal., Viansone A; Medical Oncology Department, Gustave Roussy Institute, Villejuif, France., André F; Unit of Molecular Predictors and New Targets in Oncology, INSERM, Gustave Roussy Institute, University Paris Saclay, Villejuif, France.; Medical Oncology Department, Gustave Roussy Institute, Villejuif, France., Martin AL; UNICANCER, Direction des Data et des Partenariats, Le Kremlin-Bicêtre, France., Everhard S; UNICANCER, Direction des Data et des Partenariats, Le Kremlin-Bicêtre, France., Jouannaud C; Institut Godinot, Reims, France., Fournier M; Institut Bergonié, Bordeaux, France., Rouanet P; Institut régional du Cancer de Montpellier-Val d'Aurelle, Montpellier, France., Vanlemmens L; Centre Oscar Lambret, Lille, France., Dhaini-Merimeche A; Institut de Cancérologie de Lorraine-Alexis Vautrin, Vandoeuvre lès Nancy, France., Sauterey B; Institut de Cancérologie de L'ouest-Site Angers, Angers, France., Cottu P; Institut Curie, Paris, France., Levy C; Centre François Baclesse, Caen, France., Stringhini S; Unit of Population Epidemiology, Division of Primary Care, Department of Health and Community Medicine, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland., Guessous I; Unit of Population Epidemiology, Division of Primary Care, Department of Health and Community Medicine, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland., Vaz-Luis I; Unit of Molecular Predictors and New Targets in Oncology, INSERM, Gustave Roussy Institute, University Paris Saclay, Villejuif, France.; Interdisciplinary department for the Organization of Patient Pathways (DIOPP), Gustave Roussy Institute, Villejuif, France., Menvielle G; Unit of Molecular Predictors and New Targets in Oncology, INSERM, Gustave Roussy Institute, University Paris Saclay, Villejuif, France.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Aug 20; Vol. 42 (24), pp. 2908-2917. Date of Electronic Publication: 2024 Jun 18.
Autor:
Lange M; ANTICIPE U1086 INSERM-UCN, Equipe Labellisée Ligue Contre le Cancer, Centre François Baclesse, Normandie Université UNICAEN, Caen, France.; Services Unit PLATON, Cancer and Cognition Platform, University of Caen Normandy, Caen, France., Lequesne J; ANTICIPE U1086 INSERM-UCN, Equipe Labellisée Ligue Contre le Cancer, Centre François Baclesse, Normandie Université UNICAEN, Caen, France.; Services Unit PLATON, Cancer and Cognition Platform, University of Caen Normandy, Caen, France., Dumas A; Aix Marseille University, INSERM, IRD, ISSPAM, SESSTIM (Economic and Social Sciences of Health and Medical Information Processing), Marseille, France., Clin B; ANTICIPE U1086 INSERM-UCN, Equipe Labellisée Ligue Contre le Cancer, Centre François Baclesse, Normandie Université UNICAEN, Caen, France.; CHU de Caen, Service de santé au travail et pathologie professionnelle, F-14000 Caen, France., Vaz-Luis I; INSERM, Gustave Roussy Institute, University Paris Saclay, Unit Molecular Predictors and New Targets in Oncology, Villejuif, France., Pistilli B; Medical Oncology Department, Gustave Roussy, Villejuif, France., Rigal O; Care Support Department, Centre Henri Becquerel, Rouen, France.; Medical Oncology Department, Centre Henri Becquerel, Rouen, France., Lévy C; Institut Normand du Sein, Centre François Baclesse, Caen, France., Lerebours F; Medical Oncology Department, Institut Curie, Saint Cloud, France., Martin AL; UNICANCER, Paris, France., Everhard S; UNICANCER, Paris, France., Menvielle G; INSERM, Gustave Roussy Institute, University Paris Saclay, Unit Molecular Predictors and New Targets in Oncology, Villejuif, France., Joly F; ANTICIPE U1086 INSERM-UCN, Equipe Labellisée Ligue Contre le Cancer, Centre François Baclesse, Normandie Université UNICAEN, Caen, France.; Services Unit PLATON, Cancer and Cognition Platform, University of Caen Normandy, Caen, France.; Medical Oncology Department, CHU de Caen, Caen, France.
Publikováno v:
JAMA network open [JAMA Netw Open] 2024 Aug 01; Vol. 7 (8), pp. e2427576. Date of Electronic Publication: 2024 Aug 01.
Autor:
Gregoraci, G, van Lenthe, F J, Artnik, B, Bopp, M, Deboosere, P, Kovács, K, Looman, C W N, Martikainen, P, Menvielle, G, Peters, F, Wojtyniak, B, de Gelder, R, Mackenbach, J P
Publikováno v:
Tobacco Control, 2017 May 01. 26(3), 260-268.
Externí odkaz:
https://www.jstor.org/stable/44652273
Autor:
Chiodi C; Cancer Survivorship Group, Inserm Unit 981 Gustave Roussy, Villejuif, France. camilakchiodi@gmail.com., Epstein J; Université de Lorraine, APEMAC, Nancy, France.; REFLIS, Paris, France.; French National Platform Quality of Life and Cancer, Paris, France., Arvis J; Cancer Survivorship Group, Inserm Unit 981 Gustave Roussy, Villejuif, France., Martin E; Cancer Survivorship Group, Inserm Unit 981 Gustave Roussy, Villejuif, France., Barbier A; Cancer Survivorship Group, Inserm Unit 981 Gustave Roussy, Villejuif, France., Di Meglio A; Cancer Survivorship Group, Inserm Unit 981 Gustave Roussy, Villejuif, France., Gillanders E; Cancer Survivorship Group, Inserm Unit 981 Gustave Roussy, Villejuif, France., Jacob G; Seintinelles, Paris, France., Menvielle G; Cancer Survivorship Group, Inserm Unit 981 Gustave Roussy, Villejuif, France., Everhard S; UNICANCER, Paris, France., Guillemin F; Université de Lorraine, APEMAC, Nancy, France.; REFLIS, Paris, France.; French National Platform Quality of Life and Cancer, Paris, France., Luis IV; Cancer Survivorship Group, Inserm Unit 981 Gustave Roussy, Villejuif, France.; Department for the Organization of Patient Pathways (DIOPP), Inserm Unit 981 Gustave Roussy, Villejuif, France., Franzoi MA; Cancer Survivorship Group, Inserm Unit 981 Gustave Roussy, Villejuif, France.
Publikováno v:
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation [Qual Life Res] 2024 May; Vol. 33 (5), pp. 1267-1274. Date of Electronic Publication: 2024 Mar 05.
Autor:
El-Khoury F; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP), Department of Social Epidemiology, Paris, Île-de-France, France fabienne.khoury@gmail.com., Mino JC; Institut Siel Bleu, Paris, France., Deschamps N; Institut Siel Bleu, Paris, France., Lopez C; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP), Department of Social Epidemiology, Paris, Île-de-France, France., Menvielle G; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP), Department of Social Epidemiology, Paris, Île-de-France, France.; INSERM, Gustave Roussy Institute, University Paris Saclay, Unit Molecular Predictors and New Targets in Oncology, Villejuif, Île-de-France, France., Dargent-Molina P; Université Paris Cité et Université Sorbonne Paris Nord, Inserm, INRAE, Center for Research in Epidemiology and StatisticS (CRESS), Paris, Île-de-France, France.
Publikováno v:
BMJ open [BMJ Open] 2024 Mar 14; Vol. 14 (3), pp. e081447. Date of Electronic Publication: 2024 Mar 14.
Autor:
Lapidari, P., Lustberg, M., Havas, J., Pagliuca, M., Bousrih, C., Jouannaud, C., Fournier, M., Jacot, W., Vanlemmens, L., Kaderbhai, C., Tredan, O., Levy, C., Martin, A-L., Gaudin, C., Menvielle, G., Franzoi, M.A., Vaz Luis, I.V., Di Meglio, A.
Publikováno v:
In Annals of Oncology September 2024 35 Supplement 2:S1078-S1079
Publikováno v:
In Revue d¿Epidémiologie et de Santé Publique June 2013 61(3):221-231
Autor:
Sassenou J; Centre for Research in Epidemiology and Population Health (CESP), Inserm U1018, Université Paris-Saclay, Villejuif, France., Ringa V; Centre for Research in Epidemiology and Population Health (CESP), Inserm U1018, Université Paris-Saclay, Villejuif, France., Zins M; National Institute for Health and Medical Research (Inserm), Population-based Epidemiologic Cohorts Units, UMS 011, Villejuif, France., Ozguler A; National Institute for Health and Medical Research (Inserm), Population-based Epidemiologic Cohorts Units, UMS 011, Villejuif, France., Paquet S; Centre for Research in Epidemiology and Population Health (CESP), Inserm U1018, Université Paris-Saclay, Villejuif, France., Panjo H; Centre for Research in Epidemiology and Population Health (CESP), Inserm U1018, Université Paris-Saclay, Villejuif, France., Franck JE; IRIS, Inserm/EHESS/CNRS, Aubervilliers, France., Menvielle G; Sorbonne University, National Institute for Health and Medical Research (Inserm), Institut Pierre-Louis Epidémiologie et Santé Publique, Paris, France., Rigal L; Centre for Research in Epidemiology and Population Health (CESP), Inserm U1018, Université Paris-Saclay, Villejuif, France.
Publikováno v:
Preventive medicine reports [Prev Med Rep] 2023 Sep 09; Vol. 36, pp. 102363. Date of Electronic Publication: 2023 Sep 09 (Print Publication: 2023).
Autor:
Ruiz de Azua G; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, IPLESP, Équipe de Recherche en Épidémiologie Sociale, Paris, France., Kousignian I; Université Paris Cité, Unité de Recherche «Biostatistique, Traitement et Modélisation des données bio-logiques» BioSTM, UR 7537, Paris, France., Vaz-Luis I; Medical Oncology Department, Gustave Roussy, Villejuif, France.; INSERM Unit 981-Prédicteurs moléculaires et nouvelles cibles en oncologie, Gustave Roussy, Villejuif, France., Di Meglio A; INSERM Unit 981-Prédicteurs moléculaires et nouvelles cibles en oncologie, Gustave Roussy, Villejuif, France., Caumette E; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, IPLESP, Équipe de Recherche en Épidémiologie Sociale, Paris, France.; Department of Maieutics, Université de Montpellier, Montpellier, France., Havas J; INSERM Unit 981-Prédicteurs moléculaires et nouvelles cibles en oncologie, Gustave Roussy, Villejuif, France., Martin E; INSERM Unit 981-Prédicteurs moléculaires et nouvelles cibles en oncologie, Gustave Roussy, Villejuif, France., Martin AL; UCBG, UNICANCER, Paris, France., Querel O; UCBG, UNICANCER, Paris, France., Vanlemmens L; Centre Oscar Lambret, Lille, France., Pistilli B; Breast Cancer Group, Institut Gustave-Roussy, Villejuif, France., Coutant C; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France., Cottu PH; Department of Medical Oncology, Institut Curie, Paris, France., Merimeche AD; Centre Alexis Vautrin, Vandoeuvre Les Nancy, France., Lerebours F; Department of Medical Oncology, Institut Curie, Saint-Cloud, France., Tredan O; Centre Léon Berard, Lyon, France., Jouannaud C; Institut Jean Godinot Reims, Reims, France., Levy C; Centre François Baclesse, Caen, France., Dumas A; Université Paris Cité ECEVE, UMR 1123, Inserm, Paris, France., Menvielle G; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, IPLESP, Équipe de Recherche en Épidémiologie Sociale, Paris, France.
Publikováno v:
Cancer medicine [Cancer Med] 2023 Sep; Vol. 12 (18), pp. 19091-19101. Date of Electronic Publication: 2023 Aug 21.